The University of Michigan-linked vaccination technology developer has pivoted from its previous focus on antimicrobial ointments for skin infections.

Blavatnik Family Foundation has made a $15m grant to Yale University to boost its life sciences-focused fund to $25m two years after it was first established.

The Edinburgh spinout has been backed by Mercia Fund Managers to support development of its kidney dialysis camouflage coating.

NeuroVision has collected $11.2m from backers including VSP Global and Johnson & Johnson for a round expected to close at $15m.

WuXi Healthcare Ventures has returned to support the drug developer's series B round, which included Taikang Insurance.

AIA led the round, which valued online health portal WeDoctor at $5.5bn, as part of a strategic collaboration deal.

UCL spinout Autolus has filed for an initial public offering on Nasdaq and plans on using the proceeds to further develop its range of cancer treatments.

The University of Leicester spinout will put the funding towards recruitment and moving its synthetic antibody operation into larger premises.